Drawing for ONCOBAX

USPTO serial 79214556

ONCOBAX

Reviewed by CopyMark Law Group

Reg. 5483194Status 709
Filing date
Status date
Registration date
Jun 5, 2018
Examiner
VAGHANI, MAYUR C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOBAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical preparations for the prevention and treatment of cancer, medicines for the prevention and treatment of cancer and vaccines for treatment and prevention of cancerSECTION 71 - CANCELLED—
009Computer programs for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; magnetic, electronic, optical, magneto-optical data media, namely, blank magnetic, electronic, optical, magneto-optical data media and prerecorded magnetic, electronic, optical, magneto-optical data media featuring information on cancer, memory cards, CD-ROMs, namely, blank CD-ROM's for recording and prerecorded CD-ROMs featuring information on cancer, digital video disks, namely, blank digital video disks and prerecorded digital video disks featuring information on cancer; optical disks, namely, blank optical disks and pre-recorded optical disks featuring information on cancer; magneto-optical disks, namely, blank magneto-optical disks and prerecorded magneto optical disks, featuring information on cancer; magnetic tapes, namely, blank magnetic tapes and prerecorded magnetic tapes, featuring information on cancer; downloadable software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; computer programs and software used for the acquisition, visualization, processing, exploitation, annotation, storage, searching, dissemination and printing of all types of medical data, especially of images obtained by a radio-graphic means, by X-ray, scanner, pet scan, ultrasonography, magnetic resonance, tomography for the purpose of cancer screening, diagnosis or treatment, in the medical, surgical and health field and in cancer research; scientific, photographic, cinematographic, optical, measuring apparatus and instruments, namely, computers, microscopes; apparatus for recording transmission and reproduction of sound or images; equipment for processing information, namely, data processing equipment, computersSECTION 71 - CANCELLED—
010Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner, radiotherapy treatment apparatus, artificial limbs, eyes and teeth; orthopedic articles, namely, artificial orthopedic implants, orthopedic bandages and splints, orthopedic braces; suture materialSECTION 71 - CANCELLED—
042Scientific research services for medical purposes in the area of cancer research, medical research services, research and development of new medical products; research in the fields of bacteriology, biology, chemistry, information services in the field of medical research in the fight against cancer; clinical research in the area of cancer research, medical research and biology medical laboratories; scientific, pharmaceutical, medical and clinical research for new treatments and pharmaceutical products, vaccines, medicines against cancerSECTION 71 - CANCELLED—
044Medical services; hospital services; medical analyses, namely, medical analysis and testing for diagnostic or treatment purposes in the area of cancer; medical expertise services, namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer; health services, namely, treatment of cancer; medical and surgical services, namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer, surgical treatment of cancer; medical imaging, radiotherapy, brachytherapy and medical dosimetry services for treating cancer; medical diagnosis services, namely, analysis and interpretation of images generated by x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner; information services in the field of the fight against cancer, namely, information on cancer treatmentSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 26, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Feb 10, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Feb 9, 2026INPCINVALIDATION PROCESSED—
Aug 20, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 20, 2024C71TCANCELLED SECTION 71—
Apr 13, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 5, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 16, 2022CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Jul 4, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 22, 2022CHLDCHANGE OF OWNER RECEIVED FROM IB—
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 23, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 6, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 17, 2018FIMPFINAL DISPOSITION PROCESSED—
Sep 5, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 5, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 20, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 20, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 14, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 14, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Feb 14, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 14, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 14, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 25, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2018ALIEASSIGNED TO LIE—
Jan 11, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 22, 2017RFNTREFUSAL PROCESSED BY IB—
Sep 2, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 2, 2017RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 28, 2017DOCKASSIGNED TO EXAMINER—
Aug 25, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 17, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance